Kailera Therapeutics, Inc. (KLRA)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Insider purchaseKaplan Andrew T. (director) bought $134.4M of stock
- Insider purchaseBCPE Perseus Investor, LP (ten_percent_owner) bought $134.4M of stock
- Insider purchaseKaplan Andrew T. (director) bought $134.4M of stock
- Insider purchaseBCLS Fund IV Investments GP, LLC (ten_percent_owner) bought $25.0M of stock
- Insider buying cluster5 insiders bought $326.8M within 14 days
- Insider purchaseKoppel Adam (director) bought $25.0M of stock
- Insider purchaseBain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P. (ten_percent_owner) bought $25.0M of stock
- Insider purchaseKoppel Adam (director) bought $25.0M of stock
- Insider purchaseRTW INVESTMENTS, LP (ten_percent_owner) bought $8.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | Renaud Ronald C JR | director | M | 38,094 | 5.25 | $199,994 |
| 2026-06-09 | Renaud Ronald C JR | director | M | 38,094 | 5.25 | $199,994 |
| 2026-04-20 | Kaplan Andrew T. | director | P | 8,398,438 | 16 | $134,375,008 |
| 2026-04-20 | Kaplan Andrew T. | director | C | 17,857,143 | — | — |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P. | ten percent owner | P | 1,562,500 | 16 | $25,000,000 |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P. | ten percent owner | C | 4,145,768 | — | — |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P. | ten percent owner | C | 16,875,000 | — | — |
| 2026-04-20 | Koppel Adam | director | P | 1,562,500 | 16 | $25,000,000 |
| 2026-04-20 | Koppel Adam | director | C | 4,145,768 | — | — |
| 2026-04-20 | Koppel Adam | director | C | 16,875,000 | — | — |
| 2026-04-20 | BAIN CAPITAL INVESTORS LLC; Bain Capital XIV General Partner, LLC; Bain Capital Fund XIV, L.P.; BCPE Perseus Investor GP, LLC; BCPE Perseus Investor, LP | ten percent owner | P | 8,398,438 | 16 | $134,375,008 |
| 2026-04-20 | BAIN CAPITAL INVESTORS LLC; Bain Capital XIV General Partner, LLC; Bain Capital Fund XIV, L.P.; BCPE Perseus Investor GP, LLC; BCPE Perseus Investor, LP | ten percent owner | C | 17,857,143 | — | — |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ten percent owner | C | 2,034,133 | — | — |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ten percent owner | C | 9,477,719 | — | — |
| 2026-04-20 | RTW INVESTMENTS, LP; WONG RODERICK | ten percent owner | P | 500,000 | 16 | $8,000,000 |
| 2026-04-20 | RTW INVESTMENTS, LP; WONG RODERICK | ten percent owner | C | 10,276,820 | — | — |
| 2026-04-20 | RTW INVESTMENTS, LP | ten percent owner | C | 10,276,820 | — | — |
| 2026-04-20 | RTW INVESTMENTS, LP | ten percent owner | P | 500,000 | 16 | $8,000,000 |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ten percent owner | C | 2,034,133 | — | — |
| 2026-04-20 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ten percent owner | C | 9,477,719 | — | — |
| 2026-04-20 | BCPE Perseus Investor, LP | ten percent owner | C | 17,857,143 | — | — |
| 2026-04-20 | BCPE Perseus Investor, LP | ten percent owner | P | 8,398,438 | 16 | $134,375,008 |
| 2026-04-20 | Koppel Adam | director | C | 4,145,768 | — | — |
| 2026-04-20 | Koppel Adam | director | P | 1,562,500 | 16 | $25,000,000 |
| 2026-04-20 | Koppel Adam | director | C | 16,875,000 | — | — |
| 2026-04-20 | BCLS Fund IV Investments GP, LLC | ten percent owner | C | 16,875,000 | — | — |
| 2026-04-20 | BCLS Fund IV Investments GP, LLC | ten percent owner | P | 1,562,500 | 16 | $25,000,000 |
| 2026-04-20 | BCLS Fund IV Investments GP, LLC | ten percent owner | C | 4,145,768 | — | — |
| 2026-04-20 | Kaplan Andrew T. | director | P | 8,398,438 | 16 | $134,375,008 |
| 2026-04-20 | Kaplan Andrew T. | director | C | 17,857,143 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-09 3
- 2026-09-09 4
- 2026-08-14 SCHEDULE 13G
- 2026-08-14 SCHEDULE 13G
- 2026-08-12 10-Q
- 2026-08-12 8-K
- 2026-08-05 SCHEDULE 13G
- 2026-07-08 4
- 2026-07-08 3
- 2026-06-11 4
- 2026-05-26 10-Q
- 2026-05-26 8-K
- 2026-04-23 SCHEDULE 13D
- 2026-04-23 SCHEDULE 13D
- 2026-04-22 4
- 2026-04-22 4
- 2026-04-20 4
- 2026-04-20 4
- 2026-04-20 4
- 2026-04-20 4